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Abstract 
BACKGROUND: Gastritis was defined as the histological presence of gastric mucosal inflammation. One of the 
most common aetiology was H. pylori. Gastrin-17 was a hormone that was secreted by G cells. H. pylori infection 
induced increased in gastrin-17 in gastritis. Therefore, this study was to investigate the relationship of gastrin-17 
with gastritis severity and H. pylori infection. 
AIM: To determine the difference in serum Gastrin-17 level based on gastritis severity and H. pylori infection. 
METHODS: A cross-sectional study enrolling 45 patients with gastritis was conducted in Haji Adam Malik General 
Hospital between April and July 2018. Endoscopy and biopsy examinations were performed to confirm the 
diagnosis of gastritis. Gastritis severity was assessed using the Updated Sydney System. The presence of H. 
pylori infection was detected by a Campylobacter-like organism (CLO) examination. Gastrin-17 level and 
demographic data were also gathered. The analysis was done using Mann Whitney and Kruskal-Wallis test. P-
value of < 0.05 was considered statistically significant. 
RESULTS: Serum Gastrin-17 level was significantly different based on gastritis severity (P = 0.001 according to 
neutrophils infiltration and P = 0.023 according to degree of atrophy), H. pylori infection (P = 0.038), and 
combined gastritis severity and H. pylori infection (P < 0.001). Serum Gastrin-17 level was higher in subjects with 
severe neutrophils infiltration, without atrophy, and with H. pylori infection. 
CONCLUSION: There was a significant difference in serum Gastrin-17 level based on gastritis severity and H. 
pylori infection. 
 
 
 
 
 
Introduction 
 
Gastritis is one of the most common digestive 
tract problems. Worldwide, the incidence of gastritis 
was 1.8-2.1 million, while in South East Asia, 583,635 
per year. The incidence of gastritis in Indonesia itself 
is very high, which is 247,396 cases from 238.452.952 
population [1]. Gastritis is defined as the histological 
presence of gastric mucosal inflammation. In acute 
gastritis, the microscopic finding is neutrophilic 
infiltration, while in chronic gastritis, mononuclear 
cells, mostly lymphocytes and plasma cells and 
macrophages dominate the microscopic findings [2], 
[13]. Chronic gastritis is classified into normal, mild, 
moderate, severe based on mononuclear 
inflammatory cells infiltration, neutrophils infiltration, 
atrophy, intestinal metaplasia [3], [4].  
H. pylori infection plays an important role in 
the development of peptic ulcer in gastritis patients. H. 
pylori infection in developing countries was about 25-
30%, where 5-27% were found in early childhood and 
50-60% were found in adults aged more than 60 years 
old [1]. H. pylori reside within the mucous layer. The 
stomach is a dangerous environment for most other 
microorganism because of its low pH. The ability of H. 
pylori to flourish in the stomach has been attributed to 
a protective mechanism such as its production of 
urease, protecting bacteria from gastric acidity by 
creating a basic microenvironment. H. pylori can 
cause both acute and chronic gastritis in inadequately 
treated H. pylori patients; Chronic gastritis can 
progress to chronic atrophic gastritis.  
Gastrin prohormone is produced by G cells 
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located within gastric antrum and corpus in response 
to vagal and gastrin-releasing peptide (GRP) 
stimulation secondary to ingestion of peptides, amino 
acids, gastric distention and an elevation of stomach 
pH. The prohormone is later processed to shorter 
peptides. Two major forms of gastrin are secreted 
which are Gastrin-17 and Gastrin-34. The major role 
of gastrin within gastric tissue is the regulation of acid 
secretion. In H. pylori infection, Gastrin levels are 
found to be consistently elevated, and normal 
physiological negative feedback control of secretion is 
lost. Furthermore, after H. pylori treatment, gastrin 
levels are decreased and normal feedback control of 
gastrin secretion is restored [4]. 
Given the high prevalence of gastritis, this 
study is aimed to determine the difference in serum 
Gastrin-17 level based on gastritis severity and H. 
pylori infection. 
 
 
Methods 
 
Study Design 
A cross-sectional study was conducted in Haji 
Adam Malik General Hospital Medan, Indonesia 
between April and July 2018 following approval from 
the Ethics Committee of the Faculty of Medicine 
Universitas Sumatera Utara and Haji Adam Malik 
General Hospital. 
 
Subject Recruitment 
Individuals who were not pregnant, aged 18 
years or older, and willing to take part in the study 
were enrolled in this study. Exclusion criteria included 
patients who had received H. pylori eradication 
therapy within the last 6 months or on antibiotic 
therapy commonly used in eradication therapy, 
concomitant use of proton pump inhibitors, H2 
receptor antagonists, NSAIDs, steroids, and alcohol 
for the last 48 hours and patients with systemic 
disease. 
Physical examination, routine blood count, 
liver and kidney function, blood sugar, amylase, and 
lipase evaluation, ECG, and abdominal ultrasound 
were conducted to assess the exclusion criteria. 
Subjects then underwent endoscopy and biopsy 
examination to establish the diagnosis of gastritis. All 
endoscopy examinations used scopes. Biopsy 
specimens were obtained from 5 places, including the 
greater and lesser curvature of the distal antrum, 
lesser curvature at incisura angularis, anterior and 
posterior wall of the proximal corpus. Additional 
biopsies were also done in suspicious regions that 
were not mentioned previously. Histopathologic 
examination was done by Anatomic Pathologists at 
Universitas Sumatera Utara blindly. Gastritis severity 
was determined using the Updated Sydney System. 
Serum gastrin levels were measured in serum 
using the ELISA human gastrin-17 (BIOHIT OYJ, 
Laipattie, Fl-00880 Helsinki, Finland). Campylobacter-
like Organism test (CLO) was performed to detect H. 
pylori. The changing of colour from yellow to red 
magenta, pink, or dark orange means positive H. 
pylori infection.  
 
Statistical Analysis 
Data from this study were analysed 
statistically using a descriptive study to obtain 
baseline characteristics. Mann Whitney U test was 
used to determine the difference in serum Gastrin-17 
levels based on H. pylori infection, while the difference 
in serum Gastrin-17 levels based on gastritis severity 
was analysed using the Kruskal-Wallis test. The 
calculation was conducted at a 95% confidence 
interval and P-value of < 0.05 was considered 
significant. 
 
 
Results 
 
A total of 45 gastritis patients were enrolled in 
this study. There were 25 (55.6%) males. The mean 
age was 51.0 (SD 12.27) years, with mean Body 
Mass Index (BMI) of 23.0 (SD 4.02) kg/m
2
. The 
majority of the ethnic background was Bataknese 
(71.1%). 
Table 1: Baseline characteristics 
Characteristics n = 45 
Gender, n (%)  
Male 25 (55.6) 
Female 20 (44.4) 
Mean age, years (SD) 51.0 (12.27) 
Mean body mass index,kg/m
2 
(SD) 23.0 (4.02) 
Ethnic background, n (%)  
Acehnese 3 (6.7) 
Bataknese 32 (71.1) 
Javanese 10 (22.2) 
Occupation, n (%)  
Housewife 11 (24.4) 
Private employee 12 (26.7) 
Government employee 4 (8.9) 
Entrepreneur 18 (40) 
Mean gastrin-17 level, pmol/mL (SD) 14.0 (12.92) 
CLO, n (%) 
Positive 
Negative 
 
23 (51.1) 
22 (48.9) 
Chronic inflammation, n (%) 
Mild 
Moderate 
Severe 
 
23 (51.1) 
7 (15.6) 
5 (11.1) 
Neutrophil infiltration, n (%) 
Normal 
Mild 
Moderate 
 
22 (48.9) 
18 (40.0) 
15 (33.3) 
Degree of atrophy, n (%) 
Normal 
Mild 
Moderate 
 
36 (80.0) 
4 (8.9) 
5 (11.1) 
 
Mean serum Gastrin-17 levels in this study 
were 14.0 pmol/mL. The result of CLO examination 
showed 23 (51.1%) gastritis patients had positive 
results. The result of the histopathological 
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examination for chronic inflammation showed 51.1% 
of patients had mild inflammation. Based on 
neutrophils infiltration, 18 (40.0%) had mild infiltration 
and 15 (33.3%) had moderate infiltration. Based on 
the degree of atrophy 4 (8.9%) patients had a mild 
degree and 5 (11.1%) had a moderate degree (Table 
1). 
The difference in serum Gastrin-17 levels 
based on gastritis severity was shown in Table 2. 
There were statistically significant differences in 
serum Gastrin-17 levels based on gastritis severity 
according to neutrophils infiltration and degree of 
atrophy (P = 0.001 and 0.023, respectively). Patients 
with severe neutrophils infiltration had the highest 
serum Gastrin-17 level in their group, while patients 
without atrophy had the highest serum Gastrin-17 
level in their group. 
Table 2: Differences in Gastrin-17 levels based on gastritis 
severity 
 N Gastrin-17, median (min-max) p* 
Chronic inflammation    
Mild 23 6.0 (0.8-33.0) 0.806 
Moderate 7 2.6 (0.8-40.0)  
Severe 15 19.5 (1.1-40.0)  
Neutrophil inflammation    
Normal 22 4.2 (0.8-40.0) 0.001 
Mild 18 14.0 (1.1-40.0)  
Severe 5 27.6 (15-40.0)  
Atrophy    
Normal 36 13.65 (0.8-40.0) 0.023 
Mild 4 5.85 (5.8-6.0)  
Moderate 5 1.5 (1.1-2.6)  
*Kruskal Wallis test. 
 
There was a statistically significant difference 
in serum Gastrin-17 levels based on H. pylori infection 
(P = 0.038). Median serum Gastrin-17 levels are 
shown in Table 3. 
Table 3: Serum Gastrin-17 levels differ based on H. pylori 
infection 
CLO Gastrin-17, median (min-max) P* 
Positive 14.2 (1.1-40.0) 0.038 
Negative 9.0 (0.8-33.0)  
*Mann Whitney U test. 
 
We also analysed the difference in serum 
Gastrin-17 level based on H. pylori infection in each 
gastritis severity group.  
Table 4: Differences in serum Gastrin-17 levels based on H. 
Pylori infection in each gastritis severity group 
Gastrin-17 Level, median (range) N 
H. pylori 
P* 
(+) (-) 
Chronic 
inflamation 
Mild 23 
5.8 
(1.5-6.0) 
10.0 
(0.8-33.0) 
0.218
 
 Moderate 7 
8.6 
(2.6-40.0) 
1,65 
(0.8-24.0) 
0.157
 
  Severe 15 
19.5 
(1.1-40.0) 
- - 
Neutrophil 
infiltrasion 
Normal 22 
5.8 
(1.5-40.0) 
2,2 
(0.8-33.0) 
0.480
 
 Mild 18 
13.8 
(1.1-40.0) 
21.8 
(10.3-26.1) 
0.750
 
 Severe 5 
27.6 
(15-40.0) 
- - 
Atrophy Normal 36 
19.8 
(8.6-40.0) 
9.7 
(0.8-33.0) 
< 0.001
 
 Mild 5 
5.9 
(5.8-6.0) 
5.8 0.346
 
 Severe 5 
1.5 
(1.1-2.6) 
-  
*Mann-Whitney U test. 
 
Based on the statistical analysis, we found a 
significant difference in serum Gastrin-17 levels in 
patients without atrophy between positive and 
negative H. pylori infection with a P value of < 0.001. 
Significantly higher serum Gastrin-17 level was 
observed in patients with positive H. pylori infection 
without atrophy (Table 4). 
 
 
Discussion 
 
Gastrin is secreted by G cells, which are 
presented in gastric antrum and duodenum. Gastrin is 
secreted in response to vagal and gastrin-releasing 
peptide (GRP) stimulation secondary to ingestion of 
peptides, amino acids, gastric distention and an 
elevation of stomach pH. The secret gastrin into the 
systemic circulation is delivered to parietal cells and 
enterochromaffin-like cells (ECL) in gastric fundus and 
cardia. Gastrin stimulated parietal cells to secrete 
gastric acid and ECL to secret histamine which also 
results in gastric acid production [14].  
H. pylori infection mostly is found in antrum at 
an early stage and in both corpus and antrum in the 
later stage of infection. It causes gastric inflammation 
which released cytokines (TNFα, IL1β, IFN gamma, 
IL8) [4], [12]. Gastric inflammation/gastritis are 
described by neutrophils infiltration level, lymphocytes 
level, present of intestinal metaplasia and atrophy. 
High level of TNFα is related to a severe degree of 
neutrophils infiltration. Because of its potent 
chemotactic and stimulatory activity on neutrophils 
and lymphocytes, high IL8 count is related to severe 
degree of chronic inflammation, neutrophils infiltration, 
atrophy and intestinal metaplasia [16]. Cytokines 
caused elevation of gastrin production. Increment of 
gastrin levels in H. pylori gastritis is also contributed 
by reduced somatostatin secreting D-cells [19]. In this 
study, Gastrin-17 levels were significantly higher in 
patients with positive H. pylori infection compared to 
negative H. pylori infection (p = 0.038). This result was 
supported by the previous study which was conducted 
by Park et al., [4] They reported fasting serum gastrin 
concentrations were significantly higher in patients 
with H. pylori infection compared to patients without 
infection (80.3 ± 23.5 vs 47.6 ± 14.1 pg/ml, p < 0.001). 
In Sheykholeslami et al., study, Gastrin-17 
was increased in corpus-predominant gastritis (p < 
0.01) [5]. However in this study, Gastrin-17 level was 
significantly higher in severe neutrophil infiltration. 
Meanwhile, in chronic inflammation, Gastrin -17 was 
higher in the severe category but was not significantly 
different.  
In our study, Gastrin-17 level tends to be 
lower in moderate atrophy (1.5 pmol/mL), and the 
highest value was observed in subjects without 
atrophy (13.63 pmol/mL) (p = 0.023). This result was 
consistent with a study that was done by Vaananen et 
al., [7], Ebule et al., [11]. In most cases, H. pylori 
colonisation occurs, causing peptic ulcer disease in 
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the antrum, gastric atrophy and achlorhydria in gastric 
corpus. H. pylori induce chronic inflammation 
eventually lead gastric to become atrophic. In atrophic 
gastritis, the mucosal gland is replaced by immature 
gland and epithelial cells which is intestinal type gland 
(intestinal metaplasia), fibrous tissue and/or pyloric 
type (resembling pyloric glands and epithelium that 
has no G cell inside) [17]. The decrement in G cell 
population causes gastrin production to decrease as 
the atrophic progress [8], [15]. Serum Gastrin-17 is 
significantly reduced in antral atrophy and coexistence 
of corpus atrophy [18].  
In conclusion, we found a significant 
difference in serum Gastrin-17 level based on gastritis 
severity and H. pylori infection. Serum Gastrin-17 
level is higher in subjects with severe neutrophil 
infiltration, without atrophy, and with H. pylori 
infection. 
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